EGFR Exon 20 Mutations in Non–Small Cell Lung Cancer

1 Views
administrator
administrator
07/14/23

Lyudmila Bazhenova, MD, reviews EGFR exon 20 insertions and treatments being studied in this setting, including amivantamab, osimertinib, and poziotinib.

Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next